Normal Values of Brain Oxygenation

Cerebral Arterial Disease Clinical Trial

Official title:

Normal Values of Cerebral Oxygenation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00512447
• Other study ID #: EK 62/07
• Status: Completed
• Phase: N/A
• First received: August 6, 2007
• Last updated: September 13, 2010
• Start date: July 2007

Study information

• Verified date: September 2010
• Source: University Hospital, Basel, Switzerland
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Federal Office of Public Health
• Study type: Observational

Clinical Trial Summary

New technology allows non-invasive monitoring of brain oxygenation (Near-Infrared-Spectroscopy). However, there are no large series of normal values in various adult age groups. We hypothesised that baseline values in patients breathing room air are lower in old patients than in younger subjects and that younger patients respond increase their brain oxygenation more in response to supplemental oxygen.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 171
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 25 Years to 95 Years

Eligibility

Inclusion Criteria:

• Age between 25 and 95 years undergoing a elective surgical procedure

Exclusion Criteria:

• History of cerebral disease

• Dependence on supplemental oxygen

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cerebral Arterial Disease
• Cerebral Arterial Diseases

Locations

Country	Name	City	State
Switzerland	Department of Anaesthesia, University Hospital Basel	Basel	BS

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland,